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REVIEW
A systematic review of standardized methods for assessment of endograft sealing
on computed tomography angiography post-endovascular aortic repair, and its
influence on endograft-associated complications
Richte C.L. Schuurmanna, PhilippeM. De Rooya, Frederico Bastos Gonçalvesb, Cornelis G. Vosc and Jean-Paul P.M. De Vriesa
aDepartment of Surgery, Division of Vascular Surgery, University Medical Centre Groningen, Groningen, The Netherlands; bDepartment of Vascular
Surgery, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal; cDepartment of Vascular Surgery, Martini
Hospital Groningen, Groningen, The Netherlands
ABSTRACT
Introduction: Although there is much attention for proper sizing of pre-operative anatomy before
(thoracic) endovascular aneurysm repair ([T]EVAR), standardized assessment of endograft position and
apposition at postoperative imaging is seldom addressed in the international guidelines. The highly
detailed three-dimensional computed tomography angiography (CTA) volumes contain valuable infor-
mation about the apposition of the endograft with the arterial wall and the position of the device
relative to anatomical landmarks in the proximal and distal landing zones, which is currently hardly
used. With proper assessment on CTA of the endograft after EVAR, the risk for future endograft-related
complications may be determined, allowing patient-tailored, risk-stratified surveillance.
Areas covered: This systematic review identified three standardized methods for assessing apposition
or position of the endograft in the proximal or distal landing zone on CTA after (T)EVAR. Quantification
of apposition and position, validation of measurement precision, and association with endograft-related
complications were extracted. Short (<10 mm apposition length) and decreasing (>0 mm) apposition
were associated with endograft-associated complications.
Expert commentary: Standardized assessment of apposition and position of the endograft in the
proximal and distal landing zones on CTA should be incorporated in post-(T)EVAR surveillance. A risk-
stratified CTA surveillance protocol is proposed.
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Endovascular aneurysm repair (EVAR) has been widely
adopted as a treatment for patients with abdominal or thor-
acic aortic aneurysms (AAA/TAA). Concern for secondary
aneurysm sac rupture as a result of endoleak makes life-long
surveillance mandatory[1]. Contrary to assessment of the pre-
operative anatomy on computed tomography (CT) angiogra-
phy (CTA) volumes, which is incorporated in international
guidelines and manufacturers’ indications for use, standar-
dized assessment of the endograft on postoperative CTA
scans is underreported.
International guidelines advise a CTA scan within 30 days
after EVAR, on which the presence of endoleak and >10 mm
endograft apposition length to the proximal and distal
arterial wall should be assessed [2,3]. When risk of failure
is present due to challenging anatomy or doubt exists
about the adequacy of sealing, a second postoperative
CTA is advised. Recent European guidelines also advise
a very late CTA scan at 5 years to evaluate sealing in the
long term, which was not included in the previous guide-
lines. The optimal time period and frequency for CTA sur-
veillance is, however, still debated. When no endoleak or
aneurysm growth is detected, further surveillance by annual
Doppler ultrasound is advised.
However, the three-dimensional (3D) CTA volumes contain
much more valuable information in addition to sensitive
detection of aneurysm growth and endoleaks, which are cur-
rently seldom used and not detectible on duplex ultrasound
or x-ray imaging. Accurate measurement of the endograft
position relative to anatomical landmarks and proximal and
distal endograft apposition with the arterial wall on the first
postoperative CTA scan can stratify the patient’s risk for future
complications [4–7]. Comparing these endograft properties
during follow-up reveals subtle changes that may precede
later complications[8].
Dedicated workstations are available, and standardized
methods for assessing the 3D aortic morphology have been
described and validated[9]. However, an overview of standar-
dized measurement methods for postoperative assessment of
the endograft position and apposition is lacking and is not
included in the guidelines.
This review provides an overview of standardized meth-
ods to assess the position of the endograft relative to an
anatomical landmark and the apposition of the endograft
onto the arterial wall at the proximal and distal landing
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zones on the CTA scan after EVAR and thoracic EVAR
(TEVAR). Validation of measurement precision and associa-
tion of measured variables with endograft-associated com-
plications are reviewed.
2. Methods
The literature review conformed to the Preferred Reporting
Items for Systematic Reviews and Meta- Analyses (PRISMA)
statement standards [10,11]. The review protocol was prospec-
tively registered in the PROSPERO database (No. 133,794).
A search in MEDLINE of the literature published between
April 2009 and April 2019 was performed between April 1
and 10, 2019, using the following keywords: endovascular
repair, aortic aneurysm, apposition, position, postoperative
standardized method, computed tomography. Two authors
(RS, PdR) independently screened the titles and abstracts for
eligibility. Discrepancies between the authors during the
search, selection, quality assessment, and data extraction
were resolved by discussion. In case of disagreement,
a third author (JPdV) was consulted. A filter for language
was not applied to the search, so studies with an English
translation could be included. The search terms for MEDLINE
are provided in Table 1. Search terms within each category
were combined by Boolean OR, and search categories were
combined by Boolean AND.
2.1. Selection criteria
Studies were included if they reported the quantitative assess-
ment on postoperative CTA of endograft apposition with the
arterial wall or endograft position relative to anatomical
landmark(s) in the proximal and/or distal landing zone in
patients with a TAAA or AAA treated by EVAR. Studies report-
ing patients treated for an aneurysm in an artery other than
the aorta or patients treated for aortic dissection were
excluded. Studies reporting on complex repair, such as fene-
strated or branched EVAR, chimney EVAR, or endovascular
sealing were excluded. Case reports, reviews, commentaries,
conference abstracts, letters to the editor, studies without
human subjects, studies reporting on fewer than 10 patients,
studies in other than the English language, and studies with-
out full-text availability were excluded. End points were the
reported endograft apposition and/or position, validation of
measurement precision, and association with endograft-asso-
ciated complications.
2.2. Data collection and quality assessment
Two authors (RS, PdR) independently performed data extrac-
tion. Data extraction included study period, study design,
sample size, inclusion criteria, exclusion criteria, follow-up
duration of CTA, follow-up duration of clinical outcome,
assessed landing zone(s), determination of endograft apposi-
tion with the arterial wall, determination of endograft position
relative to an anatomical landmark, the measurement method-
(s), validation of measurement precision, and association with
endograft-associated complications. Quantitative analysis was
performed if no significant heterogeneity was present.
Continuous variables are presented as the median and inter-
quartile range [quartile 1, quartile 3] or as the mean ± stan-
dard deviation.
Uniform terminology has been used to increase the read-
ability of this review. The apposition of the endograft fabric
with the arterial wall, which is also called seal, sealing, attach-
ment, or contact, is referred to as ‘apposition.’ The position of
the endograft edge relative to an anatomical landmark, which
is also called deployment accuracy or distance to (target)
vessel or artery, is referred to as ‘position.’
Risk of bias for the association between endograft apposi-
tion and/or position and endograft-associated complications
was assessed for those studies designed for comparison (i.e.,
case-control or cohort studies). The quality of the studies was
assessed with the Newcastle-Ottawa Scale for assessing the
quality of non-randomized studies, which is recommended by
the Cochrane Collaboration. The Newcastle-Ottawa Scale
includes bias analysis of selection of the study groups (four
items), the comparability of the groups (two items), and the
ascertainment of the exposure or outcome of interest for case-
control or cohort studies (three items)[12].
Quality of the described measurement methods was assessed
by reproducibility and validation of measurement precision.
Reproducibility of the method was deemed valid when the
study reported the software that was used for the measurement
and potential post-image processing, the steps that were taken
to perform the measurement, and the choices that were made
Table 1. Search terms in MEDLINE database.
No. Category Search terms
1 Endovascular
repair
repair, evar, tevar, endograft, endoprosthesis
2 Aortic aneurysm aort*, aorta[MeSH Terms], aneurysm
3 (Ap)position seal*, apposition*, deploy*, position*, place*,
geometr*, morphology*
4 Postoperative after, post, control, surveillance, follow-up
5 Standardized
method
software, workstation, measur*, protocol*, method*,




CT, ‘computed tomography’, CTA, ‘computed
tomography angiography’
Article highlights
● Current international guidelines lack advice for proper assessment of
the apposition of endografts on computed tomography angiography
(CTA) surveillance after endovascular aneurysm repair.
● Endograft apposition with the arterial wall and position relative to
anatomic landmarks can adequately be assessed with three standar-
dized methods:
● Method A. Distance along the centerline between two orthogonal
planes;
● Method B. Distance over the arterial wall between two three-
dimensional coordinates;
● Method C. Surface area between two boundary planes.
● Patients with a short apposition length (<10 mm) on the first post-
operative CTA scan are at increased risk for endograft-associated
complications. Change of apposition and position on further CTA
follow-up can also identify patients at risk for later endograft-asso-
ciated complications.
● Risk-stratified post-EVAR surveillance includes postoperative CTA
scans for patients at risk for endograft failure and should not be
duplex ultrasound only.
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for steps that are open to interpretation. Measurement precision
was deemed valid when a quantitative measure was given of the
intra- and/or interobserver variability, such as the mean
difference (MD) and the repeatability coefficient (RC). The mea-
surement methods used in the studies were marked as high
quality – reproducible and validated; medium quality – reprodu-
cible, but not validated; or poor quality – not reproducible.
3. Results
The search resulted in 538 items, which were screened for
eligibility. After a detailed screening of titles and abstracts,
515 were removed for not meeting the inclusion and exclu-
sion criteria. After the 23 full-text papers were read for elig-
ibility, 10 additional studies were removed because eight
studies did not include measurement of endograft position
relative to an anatomical landmark or endograft apposition
with the arterial vessel wall, one study measured these para-
meters from 2D digital subtraction angiography images, and
one study reported measurements on fewer than 10 patients.
The remaining 13 studies were included in this review [4–
8,13–20]. A flowchart of the selection procedure is shown in
Figure 1. The characteristics of included studies are summar-
ized in Table 2. Quantitative analysis was not performed
because of the heterogeneity of study design, patient inclu-
sion, end points, follow-up, and measurement methods.
Five studies assessed the endograft in the proximal landing
zone in the aortic neck after EVAR [8,14,17,19,20], three studies
assessed the distal landing zone in the common iliac arteries
(CIAs) after EVAR [6,7,16], and three studies assessed proximal
and distal landing zones [4,5,15]. One study assessed the
proximal landing zone after TEVAR[13], and one assessed the
distal landing zone after TEVAR[18].
3.1. Quality assessment
Two cohort studies were designed to compare patients with or
without exposure to insufficient proximal or distal apposition
(<10 mm) after EVAR [4,5], and one cohort study was designed
to compare patients with or without exposure to inaccurate
landing in the distal landing zone (>5 mm) after TEVAR
(Supplementary Table 1)[18]. Risk of bias for selection was low
(mean score, 3.7 of 4) but was high for comparability (mean
score, 0.7 of 2) and for outcome (mean score, 1.3 of 3). Seven
studies were designed to compare patients with endograft-asso-
ciated complications, AAA-associated complications, or re-inter-
vention to controls with endograft apposition or position as an
end point (Supplementary Table 2) [4,6–8,13,15,19]. Risk of bias
for selection was low (mean score, 3.6 of 4) but high for compar-
ability (0.3 of 2) and moderate for exposure (1.6 of 3).
3.2. Measurement methods
The studies described three methods to quantify endograft
apposition and position:
● Method A determines the length over the centerline
between two orthogonal boundary planes that include
a proximal and a distal point of reference (Figure 2(a)).
The method has been used for the determination of
apposition and position of the endograft within the
artery and requires a dedicated vascular workstation
that facilitates a centerline reconstruction with ortho-
gonal planes. Precision of the measurements has only
been validated for the distance between the distal
edge of the endograft limb and the iliac artery bifurca-
tion[7]. The method has been used to assess proximal
endograft apposition in the aortic neck [4,5,14,15,19],
proximal endograft position in the aortic neck relative
to the lowest renal artery [4,5] or relative to the super-
ior mesenteric artery (SMA)[15], distal endograft appo-
sition in the CIAs [4–7,15,16], distal endograft limb
position in the CIAs relative to the iliac bifurcation
[6,7,15,16], proximal position of the thoracic endograft
relative to the left subclavian artery (LSA)[13], and
distal position of the thoracic endograft relative to
the celiac trunk[18].
● Method B determines the distance over the arterial
wall between two 3D coordinates that are located on
the arterial wall (Figure 2(b)). The method has been
used for the determination of apposition and position
of the endograft within the artery. It requires 3D coor-
dinates, a segmentation of the aortic lumen, and dedi-
cated post-processing software for automated
geometric calculations. Measurement precision has
been validated for proximal apposition in the aortic
neck and for the distance between the proximal edge
of the endograft fabric and the renal arteries [17,20].
The method has been used to determine endograft
apposition in the aortic neck [8,17] and endograft
position in the aortic neck relative to the renal arteries
[8,17,20].
● Method C determines the surface area over the arterial
wall between two boundary planes to determine endo-
graft apposition with the arterial wall (Figure 2(c)).
When the total area of the potential landing zone is
also determined, the percentage of landing zone cover-
age can also be assessed. The method requires 3D
coordinates or vectors to define the planes,
a segmentation of the aortic lumen, and dedicated
post-processing software for automated geometric cal-
culations. Measurement precision has been validated
for the apposition surface area in the aortic neck[17].
The apposition surface area has been determined in the
aortic neck in three studies [8,14,17].
3.3. Validation of measurement precision
Precision of the measurements was evaluated in four stu-
dies [4,7,17,20]. The first study validated interobserver varia-
bility for determination of apposition and position lengths
with use of method B and apposition surface area by
method C in the proximal aortic neck in a series of 24
elective EVAR patients on the first postoperative CTA scan
[17]. Mean differences (MD) of length calculations with
method B were 0.2 to 0.7 mm, with RCs of 4.1 to 5.7 mm.
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Figure 1. Flow diagram of study inclusion. DSA, digital subtraction angiography.
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Table 2. Overview of measurement methods in studies that met the inclusion criteria in chronological order.
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These levels corresponded with the precision of determin-
ing endograft position in the aortic neck in a second study
with 24 patients (MD, 0.2–0.3 mm; RC, 3.2–3.4 mm)[20].
Precision of measuring position or apposition length in the
aortic neck by method A has not been validated, but neck
length was measured with a similar method and validated
in a study with 30 patients that reported similar precision
(MD, 1.5 mm; RC, 5.5 mm)[4]. Precision of measuring
position of the distal endograft edge relative to the CIA
bifurcation by method A was validated in a study with 30
patients that reported slightly higher precision (MD, 0 mm;
RC, 2 mm)[7]. Precision of apposition surface area calcula-
tions in the aortic neck by method C was also assessed (MD,
9 mm2; RC, 307 mm2)[17]. In addition, accuracy of the sur-
face area calculations was tested in vitro, which showed an
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b Last CTA on which endograft apposition or position were determined.
S: selection, C: Comparability, E: Exposure, O: Outcome, IFU: instructions for use, FU: follow-up, CIA: common iliac artery
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C has not been validated for the proximal and distal landing
zones of the thoracic aorta, and methods B and C have not
been validated for the distal landing zone in the CIAs[17].
3.4. Arterial wall apposition and position relative to
anatomic landmarks
Apposition of the endograft with the arterial wall and/or
position relative to an anatomical landmark was assessed in
10 studies. Three studies reported a quantitative value of
apposition length in specific patient populations (either
with or without specific complications or in a consecutive
cohort) [8,14,19]. A fourth study did not measure apposition
but did measure fixation length, which included the bare
stent[15]. Four studies assessed the distal apposition in the
CIAs in specific patient groups (either with or without spe-
cific complications or a consecutive cohort) [6,7,15,16]. The
findings of these studies are reported in Table 3.
Two studies reported the distance between the proximal
edge of the endograft fabric and the lowest renal artery or
both renal arteries in a specific patient population [8,20]. Four
studies assessed the distance between the covered distal edge
of the endograft limbs and the iliac bifurcation [6,7,15,16]. One
study reported the position in the proximal landing zone
relative to the LSA post-TEVAR[13], and one study reported
the position in the distal landing zone relative to the celiac
trunk post-TEVAR[18]. The findings of these studies are
reported in Table 4. In addition, two studies categorized
good (>10 mm) or bad apposition in the proximal and distal
landing zones in specific patient groups [4,5]. One study cate-
gorized good or bad position within 5 mm from the target
renal artery in the proximal landing zone after EVAR[4]. No
studies reported proximal or distal apposition after TEVAR.
3.4.1. Reported values of apposition and position
Schuurmann et al. determined changes in apposition and posi-
tion on CTA after EVAR to detect early caudal displacement of the
device in order to predict type IA endoleak[8]. Apposition length,
apposition surface area, and distance between the endograft
fabric and both renal arteries were measured with methods
B and C on the first postoperative CTA scan and a late (>1 year)
CTA scan of patients with and without endograft-related com-
plications (type IA endoleak and migration >10 mm). The late
scan was the latest scan without reported complications for the
type IA endoleak and migration groups and the latest available
scan for the control patients (>1 year). Apposition had decreased
significantly during follow-up in the complication groups but
had increased significantly in the control patients as a result of
aneurysm shrinkage. The shortest distance between the graft
fabric and the renal artery had increased significantly in the
complication groups and increased to lesser extent, but also
significantly in the control group.
Wang et al. quantified the influence of proximal neck
anatomy on contemporary outcomes in a cohort of AAA
patients with highly angulated aneurysm necks treated
with the Aorfix endograft (Lombard Medical, Oxfordshire,
UK)[19]. Apposition length was measured with method
A on the first postoperative CTA scan, with and without
endograft-associated complications (migration >10 mm, sac
expansion >5 mm, and type IA endoleak) and appeared not
to be significantly different. Definition of the distal end of
the apposition was unclear, so the measurements were not
reproducible.
Welborn et al. evaluated the clinical outcome and imaging
findings of the AFX endograft (Endologix, Irvine, CA)[14]. They
used methods A and C to measure the apposition length and
surface of patients treated with the AFX; however, definition of
the surface area calculation was not clear, so these measure-
ments were not reproducible. Apposition length exceeded the
neck length by 5.1 ± 13 mm. The average surface area was 19
± 13 cm2, and greater apposition surface area was associated
with sac regression.
Waasdorp et al. investigated the importance of iliac fixation
in the proximal and distal landing zones of the Talent endograft
(Medtronic, Santa Rosa, CA) on the first postoperative CTA scan
[15]. The proximal fixation length included the 15-mm bare
Figure 2. Schematic representation of published methods for determination of endograft apposition with the arterial wall, and position relative to the target vessels.
The figure displays the proximal landing zone for EVAR, but the methods also apply to both proximal and distal landing zones for EVAR and TEVAR. Method
A defines the length over the centerline between two orthogonal planes. Endograft position is measured from the orthogonal plane through the orifice of the target
vessel (OP1) and the orthogonal plane through the top of the endograft fabric (OP2). Endograft apposition is measured from the orthogonal plane with full proximal
(OP3) and distal (OP4) circumferential apposition. Method B defines the length between 3D coordinates over the arterial wall with dedicated post-processing
software. Endograft position is calculated as the shortest distance between the target vessel and the endograft fabric edge circumference. Endograft apposition is
calculated as the shortest distance between the endograft fabric edge circumference and the distal apposition circumference in the orthogonal plane (OP4). Method
C defines the apposition surface area between the endograft fabric edge circumference and the distal apposition circumference in the orthogonal plane (OP4),
which is calculated automatically by dedicated post-processing software.


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































EXPERT REVIEW OF MEDICAL DEVICES 691
stent, and distal fixation length was the same as apposition
length. The proximal and distal fixation lengths were both
significantly shorter in patients with migration (≥10 mm) than
in the controls. The distance between the distal edge of the
endograft and the iliac bifurcation was not significantly
different.
Schuurmann et al. reported the 3D deployment accuracy of
the endograft relative to both renal arteries on the first post-
operative CTA scan[20]. Partial coverage of the renal artery
orifice occurred in 30%, and low deployment (>3 mm distally
from the lowest renal artery) occurred in 26%. Measurements
of these distances by method A and method B were compared
in a subset of 24 patients. Distance measurement between the
contralateral (highest) renal artery and the endograft over the
centerline by method A underestimated the distance over the
(outer) curve versus method B by 20%.
Bastos Gonçalves et al. evaluated the dynamics of the iliac
attachment zone after EVAR and the association with clinical
events[7]. Apposition length in CIAs with seal complications
was significantly shorter in patients with seal complications
(type IB endoleak or need of iliac limb extension), and the
distance between the distal edge of the endograft and the
iliac bifurcation was significantly longer. Longer apposition
length was associated with fewer iliac seal complications
(odds ratio, 0.94 per mm increase) in multivariate analysis.
Roos et al. determined underlying causes of type IB and
type III endoleaks and identified anatomical factors associated
with iliac re-intervention after EVAR[6]. Apposition length in
the CIAs that underwent re-intervention of the iliac endograft
was significantly shorter than in the contralateral, non-treated
limbs. The distances between the distal edges of the endo-
graft and the iliac bifurcations were not significantly different.
Taneva et al. evaluated the chronological distal sealing
zone changes after EVAR in 52 CIAs[16]. During a follow-up
of 3.1 ± 1.4 years, the apposition length decreased from 32.1 ±
14.7 mm to 30.8 ± 15.1 mm. The distance between the distal
edge of the endograft and the iliac bifurcation increased from
19.5 ± 11.9 mm to 21.2 ± 12.8 mm. The significance of these
changes was not assessed.
Kotelis et al. identified morphologic factors affecting type
IA and IB endoleak formation and bird-beak configuration
after TEVAR[13]. The distance between the top of the fabric
and the LSA on the first postoperative CTA was significantly
shorter in patients with bird-beak configuration. Comparison
of endograft position in patients with and without endoleak
was incomplete.
Berezowski et al. investigated the accuracy of endograft
deployment in the distal landing zone during TEVAR in 59
patients with a landing zone <40 mm where the aim was to
deploy the endograft just above the target vessel, which was
the celiac trunk (74%), SMA (24%), or renal artery (2%)[18]. The
median distance was 10.0 [6.5, 16.0] mm, and the target vessel
was covered in three patients (one complete coverage, two
partial). Accurate landing (<5 mm from target vessel) was
achieved in only 10 patients. Primary type IB endoleak
occurred less frequently in patients with accurate landing
(0% vs. 33%). The difference between accurate and inaccurate
landing was not significant for late-type IB endoleaks occur-
rence (10% vs. 14%).
3.4.2. Categorized short apposition (<10 mm) and
suboptimal deployment (>5 mm from renal artery) into
cohorts
Bastos Gonçalves et al. evaluated the predictive value of the
first postoperative CTA characteristics for aneurysm-associated
adverse events as a means of patient selection for risk-adapted
surveillance[4]. Apposition length in the proximal and distal
landing zones and position relative to the target renal artery in
the proximal landing zone were measured with method A on
the first postoperative CTA scan in a series of 131 patients
treated with the Excluder endograft (W. L. Gore, Flagstaff, AZ).
They identified 18 patients (14%) with short proximal apposi-
tion length, 22 patients (17%) with short distal apposition, and
38 patients (29%) with suboptimal position (>5 mm). Short
seal length and presence of endoleak on the first postopera-
tive CTA scan were associated with AAA-related complications
(endoleak type IA, IB, III, or undefined; AAA growth >5 mm,
migration >10 mm, device failure, and AAA-associated death,
rupture, or re-intervention) during 4.1 [2.1, 6.1] years of follow-
up. Suboptimal position was not associated with AAA-asso-
ciated complications. Patients were categorized as high risk (n
= 69) and low risk (n = 62). High-risk patients were considered
to have short proximal and/or distal apposition length and/or
any endoleak on the first postoperative CTA scan. Neck length
was similar between the high-risk (32.9 ± 14.2 mm) and low-
risk (32.4 ± 15.3 mm) groups. High-risk patients had increased
risk for AAA-related complications. Short proximal and/or dis-
tal apposition length was associated with a hazard ratio
of 3.89.
Baderkhan et al. also examined whether it may be possible
to identify patients at low risk of complications based on their
first postoperative CTA[5]. Apposition length in the proximal
and distal landing zones was measured with method A on the
first postoperative CTA scan in a series of 326 patients.
Patients were categorized as high risk (n = 114) or low-risk
(n = 212) and were considered high risk when they had short
proximal and/or distal seal zone and/or any endoleak on the
first postoperative CT scan. Aortic neck length was similar
between the high-risk (23.8 ± 13.8 mm) and low-risk (22.0 ±
13.9 mm) patients. High-risk patients had increased risk for
AAA-related complications (migration >10 mm, AAA growth
>5 mm, rupture, or endoleak type IA, IB, III, or undefined) and
AAA-associated re-intervention during 4.8 ± 3.2 years of fol-
low-up. Short proximal apposition length was associated with
an odds ratio of 26.6, and short distal apposition length was
associated with an odds ratio of 37.6 for AAA-related events.
4. Discussion
This systematic review provides an overview of the studies
that described a standardized method for assessing endograft
apposition with the arterial wall or position of the endograft
relative to the target vessel(s) in the proximal and distal land-
ing zones after (T)EVAR and the association with AAA-related
complications.
Standardized methods that have been described in the
literature can be grouped into three categories. Method
A requires a dedicated vascular workstation with a centerline
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reconstruction. The advantage of this method is that physi-
cians who are familiar with pre-operative sizing on
a workstation can assess the postoperative CTA scans in
a similar and reproducible way. The major disadvantage of
this method is that the 3D orientation of the endograft within
complex aortic morphology is simplified to a cylinder-shaped
reconstruction, which may under- or overestimate the true
apposition and position lengths of the endograft within the
artery. In highly curved anatomy, the lengths will be under-
estimated in the outer curve and overestimated in the inner
curve (Figure 2). An average underestimation of 20% can be
expected in the outer curve[20]. Tilted deployment of the
endograft edge toward the axis of the aorta is also not
accounted for with method A.
Methods B and C determine the lengths and surface area
over the aortic wall and, therefore, appreciate the 3D shape of
the artery and the tilted deployment of the fabric edge. The
downside is that specialized geometric post-processing soft-
ware is required, such as Vascular Image Analysis prototype
software (VIA; Endovascular Diagnostics BV, Utrecht, The
Netherlands). Methods B and C may also be more intuitive,
since the computer-assisted calculations in 3D are clearly
visualized. The average total measurement time was estimated
at <5 min for method A and was 8.0 ± 1.5 min for method
B [4,20]. Comparison between methods A, B, and C was not
possible because of heterogenic study design, patient inclu-
sion, end points, and follow-up.
Measurements in the infrarenal aortic neck have been vali-
dated for methods A, B, and C and in the CIA for method A,
with similar outcomes. The mean difference between obser-
vers is less than 1 mm, and 95% of paired observations are
within 6 mm. The measurements have not yet been validated
for the thoracic aorta.
A short proximal apposition length (<10 mm) has been asso-
ciated with AAA-associated complications, including type IA, IB, III,
or undefined endoleak, aneurysm growth, migration, device fail-
ure, and AAA-related death, rupture, or re-intervention [4,5].
However, the study by Schuurmann et al. found no significant
differences in proximal apposition on the first postoperative CTA
scan of patients who developed late (>1 year) type IA endoleak or
migration versus patients without these complications[8]. These
different findings are probably caused by differences in patient
selection and end points. On a follow-up CTA scan, the apposition
and position of the endograft differed significantly between
patients who later developed type IA endoleak or migration com-
pared with patients without endograft-related complications[8].
This may emphasize the need for more than one CT scan during
EVAR follow-up in the first 5 years after the primary procedure.
A short apposition length (<10mm) in the distal landing zone
on the first postoperative CTA scan has been associated with
AAA-related complications after EVAR (defined as type IA, IB, III,
or undefined endoleak, aneurysm growth, migration, device fail-
ure, AAA-related death, rupture, or re-intervention) [4,5], and
distal apposition was significantly shorter in patients with com-
plications (defined as limb retraction, CIA dilatation, type IB
endoleak, iliac extension, re-intervention, or migration) [6,7,15].
The distance between the edge of the endograft and the iliac
bifurcation on the first postoperative CTA scan was longer in
patients with distal complications (defined as limb retraction, CIA
dilatation, type IB endoleak, or iliac extension) [7] but was not
associatedwith endograft-related complications (defined as type
IA, IB, III, or undefined endoleak, aneurysm growth, migration,
device failure, AAA-related death, rupture, or re-intervention) in
other studies [4,6,15]. These different findings could be caused
by shorter clinical follow-up of the studies that found no associa-
tion, and by different end points.
Only one study reported endograft-related complications
after TEVAR. Primary type IB endoleak was associated with
inaccurate landing (>5 mm from target vessel)[18]. Late-type
IB endoleak was not associated with inaccurate landing, pos-
sibly due to the low number of complications (n = 8).
4.1. Limitations
All of the studies were retrospective observational studies,
which is a limitation and should be taken into account when
considering the recommendations in this review. Some studies
were case series and not designed for group comparison.
Several studies were limited by small numbers, especially of
patients who developed complications, or by limited follow-
up. Studies assessing apposition after TEVAR were lacking.
Only two studies assessed position after TEVAR, of which the
measurements were not validated. More research is needed to
define adequate apposition and position in the proximal and
distal landing zones of the thoracic aorta and the association
with TEVAR-related complications. The studies were too het-
erogeneous in design, patient inclusion, follow-up, and end
points, so pooling of data was not possible.
5. Conclusion
This systematic review has described three standardized meth-
ods to assess apposition of the endograft with the arterial wall
and position relative to the target vessels on post-(T)EVAR
CTA, each with pros and cons, but similar precision. Proper
EVAR surveillance should include an assessment of the endo-
graft apposition on postoperative CTA scans to stratify risk for
later endograft-related complications. We should use the
information of the CT scans to their full extent, so we can
justify the exposure to contrast and radiation. Proximal and
distal apposition length <10 mm is insufficient, and a decrease
of apposition during follow-up predicts later seal failure. If
these signs are determined on a post-EVAR CT scan, it is
advised to consider treatment or perform regular CTA follow-
up instead of duplex ultrasonography, especially in high-risk
patients. The literature on TEVAR is insufficient for proper
advice on postoperative surveillance.
6. Expert opinion
Standardized post-EVAR surveillance of apposition and posi-
tion of the endograft in the proximal and distal landing zones
is feasible and can be derived from arterial phase CTA scans.
With use of these calculations, some EVAR-associated compli-
cations may be detected in an early stage or may even be
predicted before they occur. This detailed information is not
available from duplex ultrasound or x-ray imaging, which
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mainly focus on detection of complications such as significant
device migration, aneurysm growth or endoleaks.
Bastos Gonçalves et al. proposed a risk-stratified surveillance
protocol after EVAR in 2013 based on sufficient apposition
(>10 mm length) and no endoleak on the first postoperative
CTA scan[4]. The use of proper measurement of apposition on
the first postoperative CTA scan was backed up by Baderkhan
et al. in 2018[5]. High-risk patients with insufficient proximal and/
or distal apposition and/or endoleak are at increased risk for later
AAA-associated complications, and annual CTA seemsmandatory.
Low-risk patients were advised only to have CTA at 5 years and to
have duplex ultrasound surveillance unless clinical suspicion
occurred. This should reduce high surveillance costs and radiation
exposure associated with EVAR. Schuurmann et al., however,
showed in 2018 that late-type IA endoleak and migration
(>1 year) were not associated with shorter apposition on the first
postoperative CTA scan but that significant changes did appear on
a later CTA scan that preceded eventual failure of effective seal[8].
We therefore propose to modify the previous risk-stratified
surveillance protocol, because patients with increased risk may
benefit from a timely second postoperative CTA scan. These
high-risk patients include those with challenging pre-operative
anatomy, such as short neck length (<10 mm), large neck
diameter (>30 mm), large aortic curvature (>50 m−1), large
aneurysm sac diameter (>65 mm), or large CIA diameter
(>19 mm) [21–26], those treated outside indications for use
[27], those with any endoleak or insufficient proximal or distal
seal (<10 mm) on the first postoperative CTA [4,5], and those
where suspicion of complications arises during follow-up, such
as >5 mm aneurysm growth. In these patients, a second post-
operative CTA is advised within 2 years, on which endograft
apposition and position should be re-assessed and compared
with the baseline values on the first postoperative CTA scan to
allow detection of continuous (subtle) deterioration of apposi-
tion over time. In any event, apposition and position should be
re-assessed on any consecutive CTA scan and compared with
previous scans to detect eventual changes. Comparison with
only the previous scan may not be sufficient when subtle
changes appear within short periods of follow-up. The pro-
posed adjusted risk-stratified surveillance protocol is shown in
Figure 3. Patients with persistent decrease of apposition may
benefit from early re-intervention before an actual type
I endoleak will appear. However, the pros and cons of such
reinterventions must be debated and should be subject of
future prospective studies before robust conclusions can be
drawn.
Figure 3. Proposal for risk-stratified surveillance protocol post-EVAR, based on endograft apposition with the arterial wall, and position relative to the target vessel
in the proximal and distal landing zones on the first and second post-operative CTA scans. IFU, instructions for use.
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